Predicting memory decline in Alzheimer's patients
Part of Brain & nervous system, Mental health clinical trials.
This study looks at past memory test scores to see if they can predict how quickly memory declines in people with Alzheimer's disease. It aims to help doctors plan better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of Alzheimer's disease
- You have had at least two memory tests (MMSE) about a year apart
- You receive care at the Memory Clinic in Gonesse, France
- You do not have another brain disease like frontotemporal dementia or vascular dementia
- You live in the Gonesse area and can continue follow-up there
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests quick new methods to measure “slowed actions” in people with stroke or memory-related brain conditions. The goal is to see whether these quick tests can help predict future outcomes and guide care.
This study looks at how “slower movement” and brain changes relate to memory and thinking problems in people with early dementia (and some related conditions). It may help researchers understand what brain differences go with these symptoms, using tests and an MRI scan.
This trial studies people diagnosed with Alzheimer’s disease who are at a moderate stage of decline. It likely involves cognitive (memory/thinking) testing and care-partner input to help track changes over time.
This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.
This study looks for brain/biological “signals” (biomarkers) that may identify Alzheimer’s disease earlier, including stages before clear symptoms. You may be followed for about 5 years, with repeated memory and thinking testing to see how these signs relate to future diagnosis.
This study follows people over time to better understand how memory and thinking complaints progress in early Alzheimer’s disease (from “subjective cognitive decline” to mild cognitive problems). It may help researchers understand who is likely to decline and how symptoms change, which could support future treatments.
Hear when a new Cognitive Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.